The European Partnership for Personalised Medicine (EP PerMed) aims to improve future healthcare for all citizens through personalised therapy, diagnosis and prevention. With a total budget of around €375 million, provided by the EU and more than 50 international partners, EP PerMed will not only significantly support the transnational development of personalised medicine approaches over the next ten years, but also their successful translation into clinical practice.
The vision of the European Partnership for Personalised Medicine (EP PerMed) is to improve health outcomes within sustainable healthcare systems through research, development, innovation and implementation of personalised medicine approaches for the benefit of patients, citizens, and society.
Within EP PerMed, several earlier European Initiatives are joined under one roof. It will continue the activities of ERA PerMed in funding transnational innovation and research projects. In addition, EP PerMed will work closely together with ICPerMed for overarching strategic activities.
EP PerMed builds on over 15 years of EU-funded consortia, initiatives & events, but also on a wide range national/regional activities and efforts in all areas of the personalised medicine value continuum.